Digital Medicine Changemakers Are Center Stage at CNS Summit 2017: Otsuka and Proteus, Akili Interactive Labs, and Pear Therapeutics to Receive CNS Summit 2017 Innovation Awards

The awardees are pioneers in Digital Medicine for achievements that include the first U.S. FDA approval of a Digital Medicine System and the first Prescription Digital Therapeutic to treat disease.

News provided by

CNS Summit

Nov 17, 2017, 07:30 ET

BOCA RATON, Fla., Nov. 17, 2017 /PRNewswire/ -- CNS Summit, a community at the intersection of life sciences and technology, will bring together key figures leading the digital transformation of the life science industry.

Chief Curator and Chair of the Scientific Program Committee, Dr. Amir Kalali, will be interviewing Dr. William Carson, CEO of Otsuka Pharmaceutical Co., Ltd. (Otsuka), and Andrew Thompson, president and CEO of Proteus Digital Health (Proteus) Eddie Martucci, CEO, and Adam Gazzaley, Chief Scientific Advisor, Akili Interactive Labs, and Bakul Patel, Center Director for Digital Health, FDA at CNS Summit 2017.

Otsuka and Proteus Digital Health, Akili Interactive Labs, and Pear Therapeutics will receive CNS Summit 2017 Innovation Awards as pioneers in Digital Medicine for achievements that include the first U.S. FDA approval of a Digital Medicine System, and the first Prescription Digital Therapeutic to treat disease.

The CNS Summit (Collaborating for Novel Solutions) is in its eighth year of bringing top leaders and innovators together to shape the future of healthcare. CNS Summit 2017 is taking place November 16th—19th, 2017 in Boca Raton, Florida. For more information, visit www.cnssummit.org.

Media Contact:

Erica Moore

[email protected]

858-324-1823

SOURCE CNS Summit